Pharmaceutical Executive Europe - August 2008 - (Page 7) Pharmaceutical Executive Europe August 2008 News & Analysis 7 Healthcare division. Investigating the influence that online and offline media, as well as family, friends and sales people, have on consumers’ purchase decisions, the survey of 1000 UK consumers also found that 53% of respondents cited company information, such as leaflets, information on packaging and company websites as the source of their purchase advice for OTC medicines. Commenting on the findings, Trevor Acreman, UK Head of Millward Brown Healthcare, said: “Healthcare brands have a long way to go before their products are as talked about online as other sectors. However, they still need to keep their finger on the pulse about what is being said about their brands online as well as offline. Word of Mouth has a big influence on purchase decisions that cannot be ignored.” The survey also found that product recommendations from friends, neighbours and colleagues were seen as the most convincing and relevant. Friends and colleagues still wield the most influence when it comes to buying OTC products. ON THE MOVE Daniel Troy, formerly chief counsel at FDA from 2001 to 2004, has been appointed a senior vice president and general counsel at GlaxoSmithKline. Mr Troy formerly represented pharmaceutical companies and trade associations in their interactions with the FDA. He assumes his new role on 2 September. Probiodrug (Germany) has announced the appointment of Professor Dr Harald Labischinski and Dr Jonathan David Turner to its board of directors. Since 2005, Prof Dr Labischinski has been chief executive officer of Combinature Biopharm AG (now: MerLion Pharmaceuticals GmbH). Following Combinature Biopharm’s acquisition of by Merlion Pharmaceuticals Pte Ltd in 2006, he has also been serving as MerLion´s chief scientific officer and member of the board of directors. Dr Jonathan David Turner has served as senior vice president, Business Development, at XL Technology Group (US) since 2005. From 2002–2005, he was head of Corporate Business Development and Corporate Pharmaceutical Licensing at Boehringer Ingelheim (Germany). Wendy Nicholls (left), previously of Norris Lincoln, is one of four new appointments at Euro RSCG Life UK. Wendy joins as copy writer. Peter Chapman, Darryl McDonald and Russell Kirk join as art directors. All four will work across the three Divisions of Rx, OTC/Vet and Med Comms. DxS (UK) has appointed of Ron Long as non-executive director. Ron has 40 years of experience in the sector: he worked with the Wellcome Foundation for over 22 years, holding divisional director appointments in Wellcome Biotechnology and Coopers Animal Health, and was group managing director of Calmic International Ltd before leaving Wellcome in 1990. He then joined Amersham as commercial director, and served as CEO for Amersham Pharmacia Biotech and vice chairman of Amersham plc, before retiring in June 2001. Jennie Conway has joined Athena (UK) as account director. Jennie brings with her seven years experience working in healthcare PR and medical education. She was most recently at Packer Forbes, where she worked on oncology projects. Her previous experience includes working in the areas of cardiology and mental health. Stockb yte/Ge tty Imag es
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 Contents From the Editor News and Analysis Calendar The Calm Before the Storm Steering Pharma in Russia Built on Sand Renaissance Man IT Meets IMI Send for the Software Specialists Know Your eMarket Last Words Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover1) Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover2) Pharmaceutical Executive Europe - August 2008 - Contents (Page 3) Pharmaceutical Executive Europe - August 2008 - Contents (Page 4) Pharmaceutical Executive Europe - August 2008 - From the Editor (Page 5) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 6) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 7) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 8) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 9) Pharmaceutical Executive Europe - August 2008 - The Calm Before the Storm (Page 10) Pharmaceutical Executive Europe - August 2008 - Steering Pharma in Russia (Page 11) Pharmaceutical Executive Europe - August 2008 - Built on Sand (Page 12) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 13) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 14) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 15) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 16) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 17) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 18) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 19) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 20) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 21) Pharmaceutical Executive Europe - August 2008 - Last Words (Page 22)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.